These discrepancies may be attributed to substantial population heterogeneity, including variations in resistin’s effects by ethnicity, sex—with stronger associations observed in postmenopausal women—and underlying comorbidities such as diabetes versus non-diabetes populations (44). This evidence concerns the gene RETN and diabetes mellitus.